Allurion Technologies 주식 (NYSE: ALUR)

에 대한 최신 뉴스 Allurion Technologies (NYSE:ALUR) 주식

Allurion Technologies

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Allurion Technologies Inc

Allurion Technologies, Inc. Warrants, each whole warrant exercisable to purchase 1.420455 shares of common stock at an exercise price of $8.10 per share of common stock

<p>For the second straight year, President <strong>Donald Trump</strong> could be a buzzworthy topic at the Cannes Film Festival—not because of a screening, but due to talks around a new biopic in development.</p>
<p><strong>What Happened:</strong> While last year's &#8220;The Apprentice&#8221; premiered at Cannes and sparked backlash from Trump himself, this year no Trump-based film is on the schedule. However, Italian producer <strong>Andrea Iervolino</strong> is shopping a new $100 million Trump biopic project to potential partners during the festival, <a href="https://deadline.com/2025/05/donald-trump-film-biopic-ferrari-producer-andrea-iervolino-1236391172/">according </a>to Deadline.</p>
<p>The Italian producer is expected to talk with potential partners at the film festival with the goal of securing the budget in order to start filming by the end of 2025 in the United States, according to the report.</p>
<p>A cast has not been announced for the potential film.</p>
<p>Unlike "The Apprentice," which showed a darker side of President Trump's rise to power, the new biopic is expected to be a positive portrayal of the president according to the report.</p>
<p>The film is described as "a major new biographical film centered on the life and legacy of Donald J. Trump – real estate mogul, television icon, and 45<sup>th</sup> and 47<sup>th</sup> President of the United States."</p>
<p>"Whether one agrees or disagrees with his politics, there's no denying Donald Trump's impact on the modern era. As a producer, I'm interested in exploring the deeper story of the man – the rise, the challenges, the resilience. Our goal is to deliver a film that is bold, balanced, and artistically ambitious," Iervolino said.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/general/entertainment/25/05/45201601/trump-wants-movies-made-in-america-again-heres-what-tariffs-on-films-could-mean-for-disney-netflix-stock">Trump Wants &#8216;Movies Made In America Again&#8217;: Here&#8217;s What Tariffs On Films Could Mean For Disney, Netflix Stock</a></strong></p>
<p><strong>Why It's Important</strong>: While it's unknown if Iervolino has worked with the Trump team or gotten rights to any material about the president, the producer could have an edge in making a film that gets approval and support from the president.</p>
<p>Filmmaker and producer <strong>Keya Morgan</strong> is listed as a collaborator on the film by Iervolino. Morgan was previously the manager for comic book legend <strong>Stan Lee</strong> and was also involved in a dispute with Lee's family after his passing. Morgan has had <strong>Donald Trump Jr.</strong> as a client in the past.</p>
<p>A quick look at Morgan's X <a href="https://x.com/KeyaMorgan">account </a>shows a cover photo of the producer with Trump.</p>
<p>"The Apprentice" struggled at the box office, grossing $4 million domestically and $17.3 million worldwide, as <a href="https://www.boxofficemojo.com/title/tt8368368/?ref_=bo_se_r_1">reported </a>by BoxOfficeMojo. The film did manage to land several award nominations, including an <a href="https://www.benzinga.com/general/entertainment/25/03/44067420/2025-academy-awards-how-to-watch-betting-odds-will-a-film-about-donald-trump-win-any-awards">Academy Award nomination </a>for <strong>Sebastian Stan</strong>, who played Trump in the film.</p>
<p>Trump and his team tried to block the movie from theaters and sent cease and desist letters to the film's team.</p>
<p>A biopic that portrays Donald Trump in a more favorable or nuanced light—potentially with the former president's backing—could attract strong interest from studios and streaming platforms. If Trump publicly supports the project, it may further boost attention through his social media channels.</p>
<p>The Cannes Film Festival runs May 13 through May 24.</p>
<p><strong>Read Next: </strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/general/entertainment/24/05/38946127/trump-movie-director-claps-back-at-criticism-lawsuit-threats-no-nice-metaphorical-way-to-de">Trump Movie Director Claps Back At Criticism, Lawsuit Threats: &#8216;No Nice Metaphorical Way To Deal With Fascism&#8217;</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>



Entertainment

Politics

Trump Fought Last Biopic — Will He Back New $100 Million Film Project With 'Balanced' Vision?

<p>Capital Link's Trending News Webinar Series featured this week a discussion with Mr. Alexander Saverys, CEO of CMB.TECH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMBT#NYSE">CMBT</a>), who shared his views on the company's diversified business model, plans for decarbonization, and his vision for a maritime industry that balances tradition with bold innovation. </p>
<h5 class="wp-block-heading"><strong>Highlights</strong></h5>
<ul class="wp-block-list">
<li>Ammonia and hydrogen are among the most promising future fuels that comply with regulations and do not emit CO2.</li>
<li>CMB.TECH is bridging the current NAV valuation gap by shifting investor focus from asset values to sustainable earnings power through a diversified business model, leveraging increased liquidity from the Golden Ocean merger and their decarbonization efforts to create long-term shareholder value.</li>
<li>The company plans on investing in long-term solutions, not waiting for regulations or subsidies, and prioritizing sustainable growth.</li>
<li>Africa is expected to be the next big thing in shipping as it will inspire new trade routes using more environmentally friendly technologies.</li>
</ul>
<p><strong>To access the full conversation, please visit the following link:</strong></p>
<p><a href="https://www.youtube.com/watch?v=Zh4CiKwge2Q">https://www.youtube.com/watch?v=Zh4CiKwge2Q</a></p>
<p><strong>The Power of Diversification</strong></p>
<p>Unlike many publicly listed shipping firms that focus on single sectors, CMB.TECH operates across dry bulk, tankers, containers, offshore wind, and more counting 250+ vessels post-merger with Golden Ocean. This approach isn't just about hedging against cyclical downturns. It is about ensuring the company's growth and sustainability for the long term. With over a century in shipping, the Saverys family provides stability as anchor shareholders.</p>
<p>"We look ahead to what ships, engines, and cargo the industry will need in the coming decades. Shipping has long investment cycles, so future proofing is essential. Diversification lets us make the right decisions at the right time, no matter where we are in the cycle" Mr. Saverys explains.</p>
<p>As a result, a key theme of the discussion was the importance of&nbsp;stability and long-term vision&nbsp;in an industry often driven by short-term gains. The company's leadership, with deep roots in shipping, brings a perspective that prioritizes&nbsp;sustainable growth over quick wins.</p>
<p>"Thinking in decades, not quarters, is what allows us to make bold moves,"&nbsp; Mr. Saverys remarked.</p>
<h5 class="wp-block-heading"><strong>Creating Sustainable Value</strong></h5>
<p>The persistent gap between shipping companies&#8217; net asset values (NAV) and their market valuations was a primary discussion topic. Mr. Saverys expressed disappointment with the market&#8217;s tendency to value shipping stocks primarily on liquidation value rather than earnings potential or strategic positioning. He noted that NAV represents just the value of ships minus debt and added that this overlooks the value of their operating platforms, technical expertise, and future earnings capacity.</p>
<p>CMB.TECH is taking concrete steps to bridge this gap. The Golden Ocean merger will increase the company&#8217;s free float from 8% to 38%, improving liquidity and making the stock more attractive to institutional investors. More fundamentally, Mr. Saverys commented that they want to be valued on their ability to produce earnings and cash flow, not just the appraised value of their vessels.</p>
<p>As disclosed in the recent Capital Markets Presentation in Oslo, post-merger with Golden Ocean, which is expected to close within Q3 2025, CMB.TECH will boast a fleet of 253 vessels with an average fleet age of 6.1 years, a contract backlog of $3 billion, capex commitments of $2.2 billion and a target leverage of 50% throughout the cycle. Also, a Fair Market Value of $11.1 billion, with an NV of around $14.9/share.</p>
<h5 class="wp-block-heading"><strong>Delivering on Zero-Carbon Ambitions</strong></h5>
<p>While some shipowners explore biofuels, LNG, or methanol, CMB.TECH is placing its chips on&nbsp;ammonia and hydrogen, the only carbon-free fuels that according to Mr. Saverys align with current emissions targets.</p>
<p>The company is already moving aggressively and is currently overseeing one of the most ambitious newbuilding programs in the industry. There are 46 vessels on order, with the first ammonia-capable ships scheduled for delivery starting in 2026. These include eight bulk carriers and one container ship entering service in 2026, followed by additional vessels through 2027 and 2028. What makes this program particularly noteworthy is that all newbuilds will be equipped to operate on alternative fuels, except in cases where engine technology isn&#8217;t yet commercially available, making it cost effective.</p>
<p>When it comes to infrastructure there are challenges as bunkering networks for ships are still underdeveloped. While dedicated ammonia bunkering infrastructure doesn&#8217;t yet exist, the global ammonia trade already moves millions of tons annually for industrial use, meaning storage and handling infrastructure exists in many ports worldwide. Mr. Saverys believes early adopters will shape the market, much as they did with LNG. For the initial phase, Mr. Saverys envisions solutions like ship-to-ship transfers using existing LPG carriers, drawing parallels to how LNG bunkering developed gradually as demand increased.&nbsp;</p>
<p>When it comes to complying with IMO's regulations, it was noted that over relying on them to solve all problems is not the way to go. While acknowledging the importance of IMO policies like those expected from MEPC 83, Mr. Saverys stressed that CMB.TECH's strategy doesn&#8217;t depend on regulatory support.&nbsp; "Our business model must stand on its own," he insists. "If zero-carbon solutions stay three times more expensive than diesel, no subsidy or tax will bridge that gap." Instead CMB.TECH is investing directly in&nbsp;fuel production and engine development, by collaborating with manufacturers like WinGD.</p>
<h5 class="wp-block-heading"><strong>Africa: The Next Frontier</strong></h5>
<p>One of Mr. Saverys' most intriguing insights was his bullish outlook on&nbsp;Africa. As its population is expected to grow by&nbsp;1 billion by 2050, he sees untapped potential in its&nbsp;young workforce, quick technology adoption, economic models, and emerging trade routes.</p>
<p>"They&#8217;ll skip some of the mistakes the Western world has made in industrializing, in developing their economies. They will look at decentralized energy production. They have been digital in banking, even before we were in Europe. They will not pull cables everywhere. They will find different solutions, and they will do it better in a more sustainable and cheaper way. Whoever wants to be successful in shipping will at one point need to have an Africa strategy" he concluded.</p>
<p><em>This content is for informational purposes only and not intended to be investing advice.</em></p>


Equities

Travel

Opinion

Trading Ideas

CMBT

CMB.TECH CEO Speaks On Shifting Investor Focus From Asset Values To Sustainable Earnings Power

<p>Mizuho  analyst Ben Chaiken   maintains Six Flags Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUN#NYSE">FUN</a>) with a Outperform and lowers the price target from $50 to $43.</p>


News

Price Target

Analyst Ratings

Mizuho Maintains Outperform on Six Flags Entertainment, Lowers Price Target to $43

<p>Mizuho  analyst Ben Chaiken   maintains Marriott Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAC#NYSE">VAC</a>) with a Outperform and lowers the price target from $112 to $105.</p>


Mizuho Maintains Outperform on Marriott Vacations, Lowers Price Target to $105

WIIM

LCID

Lucid Group shares are trading higher after the company announced incentives on its Air sedan lineup.

<p><strong>Lucid Group Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) shares are trading higher Friday after the company announced substantial incentives on its Air sedan lineup, offering discounts of up to $20,500<a href="https://www.benzinga.com/tech/25/05/45311264/tesla-rival-lucid-offers-over-20000-discount-on-air-sedan-amid-auto-tariff-impact"> through the end of May. </a></p>
<p><strong>What To Know: </strong>The move comes as the company attempts to stimulate demand in the face of potential margin pressure from recently announced tariffs by the Trump administration, which it says could impact profitability by as much as 8% to 15%.</p>
<p>Lucid's discount offer includes a combination of federal EV credits, trade-in bonuses and brand-specific incentives across its Touring, Pure and Grand Touring trims. Notably, customers trading in a Tesla vehicle can also access a $4,000 bonus, adding to the stackable benefits.</p>
<p>In its recent fourth-quarter earnings call, Lucid reported a <a href="https://www.benzinga.com/25/05/45244989/lucid-group-q1-2025-earnings-tesla-rival-announces-58-increase-in-deliveries-plans-to-introduce-a-mid-size-platform-in-2026">58% year-over-year increase</a> in vehicle deliveries. The company also confirmed plans to expand into the mid-size vehicle segment by 2026 and aims to reach 20,000 vehicle deliveries this year. Additional updates included its acquisition of assets from bankrupt EV maker Nikola and the hiring of over 300 former Nikola employees. Lucid also raised over $1 billion through convertible notes to support its scaling efforts.</p>
<p><strong>LCID Price Action:</strong> Lucid shares were up 7.58% at $2.48 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a></p>
<p><strong>Read Next:</strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/25/05/45319531/cathie-wood">Cathie Wood Says AI Will &#8216;Disrupt The Traditional World Order&#8217; And Replace Search Engines Like Google</a></strong></li>
</ul>



Movers

What's Going On With Lucid Shares Today?

<p>The <a href="https://www.benzinga.com/cannabis">cannabis industry</a> just wrapped one of the busiest earnings weeks of the quarter, with more than ten companies reporting financials—including Curaleaf, GTI, Trulieve, Verano, Cronos Group and IIPR. The results revealed a widening gulf between U.S. plant-touching operators and asset-light or international players, sparking mixed reactions across capital markets. Meanwhile, headlines from Washington, Missouri and Colorado added new regulatory wrinkles, and companies like Rove and Swade made strategic expansion moves.</p>
<p>Here's everything you need to know.</p>
<h2 class="wp-block-heading">Earnings Season: Winners, Losers And The Market Divide</h2>
<h3 class="wp-block-heading">Trulieve Beats Expectations on Revenue and EPS</h3>
<p><strong>Trulieve</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>) reported $297.8 million in Q1 revenue and an adjusted loss of 2 cents per share, beating analyst expectations. The company posted strong gross margins (62%) and generated $51 million in operating cash flow, ending the quarter with $329 million in cash. It also expanded its retail footprint to 229 dispensaries. <a href="https://www.benzinga.com/25/05/45253074/trulieve-q1-earnings-revenue-eps-beat-estimates-on-strong-margins-cash-flow">Read more on Benzinga</a></p>
<h3 class="wp-block-heading">Curaleaf Posts $310 Million Revenue, Focuses on Global Growth</h3>
<p><strong>Curaleaf</strong> (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CURA#TSX">CURA</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) reported Q1 revenue of $310 million, a 9% YoY drop. The company posted a $54.8 million net loss but highlighted 74% YoY international growth and continued rollout of new brands like Select FormulaX and Anthem. It ended the quarter with $122 million in cash and $65 million in adjusted EBITDA.</p>
<h3 class="wp-block-heading">Cronos Group Reports Profit, Margin Expansion</h3>
<p><strong>Cronos Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CRON#TSX">CRON</a>) posted $32.3 million in Q1 revenue, a 28% YoY increase, and net income of $7.7 million. Gross margins jumped to 43%, driven by flower sales in Israel and extracts in Canada. The company also authorized a $50 million share repurchase program. <a>Read more on Benzinga</a></p>
<h3 class="wp-block-heading">Green Thumb Industries Holds Revenue, Margins Slip</h3>
<p><strong>Green Thumb Industries</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>) reported flat Q1 revenue of $248 million. Gross margin fell to 48%, and net income landed at $10 million. Adjusted EBITDA was $75 million. The company ended the quarter with $136 million in cash and operates 91 dispensaries. <a href="https://www.benzinga.com/news/earnings/25/05/45291060/cannabis-earnings-show-market-split-us-plant-touching-stocks-drop-iipr-and-cronos-up">Read more on Benzinga</a></p>
<h3 class="wp-block-heading">Verano Sees Revenue Dip, Margin Pressure</h3>
<p><strong>Verano Holdings</strong> (Cboe CA: VRNO) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTCQX">VRNOF</a>) reported $209.8 million in revenue, down 5% YoY. The company posted a net loss of $11.5 million and a 47% gross margin. Cash on hand totaled $84 million. <a href="https://www.benzinga.com/news/earnings/25/05/45291060/cannabis-earnings-show-market-split-us-plant-touching-stocks-drop-iipr-and-cronos-up">Read more on Benzinga</a></p>
<h3 class="wp-block-heading">The Cannabist Contracts Revenue, Continues Restructuring</h3>
<p><strong>The Cannabist Company</strong> (Cboe CA: CBST) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CBSTF#OTCQX">CBSTF</a>) reported $87.4 million in revenue and a net loss of $32.2 million. The company exited several markets, improved adjusted gross margin to 35.7%, and is prioritizing liquidity. <a href="https://www.benzinga.com/news/earnings/25/05/45291060/cannabis-earnings-show-market-split-us-plant-touching-stocks-drop-iipr-and-cronos-up">Read more on Benzinga</a></p>
<h3 class="wp-block-heading">MariMed Stays Flat, Margin Compression Continues</h3>
<p><strong>MariMed</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTCQX">MRMD</a>) generated $38 million in revenue and a net loss of $5.4 million. Gross margin narrowed to 40%, and adjusted EBITDA declined to $2.6 million. The company expanded Betty's Eddies into 70 new storefronts. <a href="https://www.benzinga.com/news/earnings/25/05/45291060/cannabis-earnings-show-market-split-us-plant-touching-stocks-drop-iipr-and-cronos-up">Read more on Benzinga</a></p>
<h3 class="wp-block-heading">IIPR Delivers Consistent REIT Results</h3>
<p><strong>Innovative Industrial Properties</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) posted $75.5 million in revenue and $40.7 million in net income. The REIT collected 97% of contractual rent and maintained a strong portfolio across 19 states. <a href="https://www.benzinga.com/news/earnings/25/05/45291060/cannabis-earnings-show-market-split-us-plant-touching-stocks-drop-iipr-and-cronos-up">Read more on Benzinga</a></p>
<h3 class="wp-block-heading">Jushi Cuts Losses, Expands in Ohio and New Jersey</h3>
<p><strong>Jushi Holdings</strong> (CSE:<a class="ticker" href="https://www.benzinga.com/stock/JUSH#CSE">JUSH</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/JUSHF#OTCQX">JUSHF</a>) posted a $17 million loss on $63.8 million in revenue. The company opened new dispensaries in Ohio and launched the Flower Foundry brand. Adjusted EBITDA rose 23% sequentially to $9.8 million.</p>
<h3 class="wp-block-heading"><strong>TerrAscend Grows Revenue, Tightens Focus on Core Markets</strong></h3>
<p><strong>TerrAscend</strong> (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TSND#TSX">TSND</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TSNDF#OTCQX">TSNDF</a>) posted $71 million in Q1 revenue, up 16% YoY, and a net loss of $12.3 million. The company continues expanding in Maryland and New Jersey while focusing on operational efficiency. Gross margin improved to 50.6%, and adjusted EBITDA came in at $10.4 million.</p>
<h3 class="wp-block-heading"><strong>GrowGeneration Revenue Drops, Outlook Withdrawn</strong></h3>
<p><strong>GrowGeneration</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) reported Q1 revenue of $35.7 million, down 8% YoY, and a net loss of $9.8 million. The hydroponics retailer cited retail headwinds and tariff impacts, retracting its full-year 2025 guidance. Gross margin held at 27.3%, and the company closed the quarter with $64.7 million in cash.</p>
<h3 class="wp-block-heading"><strong>NewLake Capital Posts Strong Profit, Steady Portfolio</strong></h3>
<p><strong>NewLake Capital Partners</strong> (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/NLCP#OTCQX">NLCP</a>), a cannabis-focused REIT, reported $13.2 million in revenue and net income of $6.5 million. The company collected 100% of rent due and declared a $0.40 per share quarterly dividend. Its portfolio remains diversified across cultivation and retail assets in key legal markets.</p>
<h3 class="wp-block-heading">Kass Warns Most Cannabis Stocks Are ‘Walking Dead'</h3>
<p>Investor <strong>Doug Kass</strong> said most public cannabis stocks are uninvestable due to debt loads and oversupply. He singled out Trulieve, TerrAscend, GTI and Glass House as the few worth watching. <a href="https://www.thestreet.com/investing/stocks/veteran-hedge-fund-manager-has-harsh-words-for-marijuana-stocks">Read more on TheStreet</a></p>
<h2 class="wp-block-heading">Regulation &amp; Politics</h2>
<h3 class="wp-block-heading">DEA Nominee Promises to Prioritize Cannabis Rescheduling Review</h3>
<p><strong>Terrance Cole,</strong> President Trump's nominee to lead the DEA, told the Senate Judiciary Committee that reviewing the marijuana rescheduling process will be a priority, though he didn't endorse the current proposal. <a href="https://www.mjbizdaily.com/">Read more on MJBizDaily</a></p>
<h3 class="wp-block-heading">Colorado Approves Regulatory Relief Bill</h3>
<p>HB25-1209 passed both legislative chambers in Colorado. The bill aims to streamline cannabis regulations and reduce unnecessary burdens on operators. Gov. Jared Polis is expected to sign it.</p>
<h3 class="wp-block-heading">Pennsylvania Considers State-Run Cannabis Sales</h3>
<p>Pennsylvania lawmakers introduced a proposal to legalize adult-use cannabis via state-run liquor stores. While unlikely to pass in its current form, the bill signals growing momentum for legalization in the state.</p>
<h3 class="wp-block-heading">Florida Tightens Ballot Rules, Threatening Future Cannabis Campaigns</h3>
<p>Governor Ron DeSantis signed a controversial new law that makes it harder for citizen-led initiatives to reach the ballot. The measure imposes a $1 million bond requirement, restricts out-of-state petitioners, and introduces felony penalties for noncompliant circulators. Critics say it could block future efforts to legalize adult-use cannabis, including the 2026 campaign supported by Trulieve and other major operators. A federal lawsuit has already been filed challenging its constitutionality.</p>
<h2 class="wp-block-heading">Brand Moves &amp; Market Expansion And Science</h2>
<h3 class="wp-block-heading">Rove Launches in Washington, Now in 14 States</h3>
<p>Rove, the fourth-largest cannabis brand by 4/20 revenue per Headset, entered the Washington market with its Diamond Vapes. The brand is now sold in 14 states, including New Jersey, New York and Ohio.</p>
<h3 class="wp-block-heading">Swade Expands to Kansas City Through BesaMe Deal</h3>
<p>Swade Cannabis, part of BeLeaf Medical, expanded its Missouri footprint to 11 dispensaries by acquiring five BesaMe Wellness locations in the Kansas City area. Its SINSE Cannabis brand is now in 90% of Missouri dispensaries.</p>
<h2 class="wp-block-heading">Science &amp; Substitution</h2>
<p>A new NIH-funded study found that consuming cannabis before drinking significantly reduced alcohol consumption and cravings among heavy drinkers. The research, conducted in a controlled lab setting, adds to growing evidence that cannabis may act as a harm-reduction substitute for alcohol—a trend also supported by industry data and shifting consumer behavior.</p>
<h2 class="wp-block-heading">Recommended Reads</h2>
<ul class="wp-block-list">
<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/05/45263739/they-turned-fruit-bouquets-into-a-500m-a-year-businessnow-theyre-selling-thc-heres-why"><strong>They Turned Fruit Bouquets Into A $500 Million-A-Year Business—Now They&#8217;re Selling THC. Here&#8217;s Why</strong></a><br />Behind the launch of Edibles.com and how Edible Arrangements&#8217; parent company is entering the cannabis space.</li>
<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/05/42033985/the-broccoli-hack-how-mexican-creators-bypassed-tiktoks-rules-to-teach-millions-about-cannabis"><strong>The Broccoli Hack: How Mexican Creators Bypassed TikTok&#8217;s Rules To Teach Millions About Cannabis</strong></a><br />A look into how content creators in Mexico use codewords and creativity to navigate censorship.</li>
<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/05/42205191/from-cannabis-youtuber-to-spotify-star-dope-as-yola-says-word-of-mouth-beats-ads"><strong>From Cannabis YouTuber To Spotify Star: Dope As Yola Says &#8216;Word Of Mouth Beats Ads&#8217;</strong></a><br />Thomas Araujo's journey from underground content to mainstream media.</li>
<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/05/42033877/youtube-star-babish-talks-cannabis-if-alcohol-blurs-the-hard-edges-weed-rounds-them-its-not-a-fi"><strong>YouTube Star Babish Talks Cannabis: &#8216;If Alcohol Blurs The Hard Edges, Weed Rounds Them&#8230; It&#8217;s Not A Fixer—It&#8217;s An Augmenter&#8217;</strong></a><br />Andrew Rea opens up about his cannabis use and how it fits into his creative life.</li>
<li><a class="" href="https://www.forbes.com/sites/javierhasse/2025/05/07/p-funk-legend-george-clinton-and-wiz-khalifa-bring-the-funk-to-weed-heres-what-that-means/"><strong>P-Funk Legend George Clinton And Wiz Khalifa Bring The Funk To Weed: Here's What That Means</strong></a><br />George Clinton reflects on his new cannabis brand, music legacy, and fighting the war on drugs.</li>
<li><a class="" href="https://www.forbes.com/sites/javierhasse/2025/05/01/this-one-decision-is-costing-america-up-to-10-billion-a-year/"><strong>This One Decision Could Cost America Up To $10 Billion A Year, According To Experts</strong></a><br />Why the U.S. is missing out on global cannabis exports—and how the clock is ticking.</li>
</ul>
<h2 class="wp-block-heading">Final Word</h2>
<p>This earnings season underscored a sobering reality: U.S. operators continue to wrestle with margin pressure, capital constraints and regulatory inertia, while international and non-plant-touching models show relative resilience. As political momentum builds around rescheduling and state-level reforms, operators are increasingly being tested on efficiency, adaptability and access to fresh capital. The divide between winners and laggards is only getting sharper.</p>


Cannabis

Earnings

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

CRON

CSE:JUSH

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GRWG

GTBIF

IIPR

JUSHI HLDGS INC CL B by Jushi Holdings Inc.

JUSHF

MRMD

NLCP

TCNNF

TSNDF

TSX:CRON

TSX:CURA

TSX:TSND

VRNOF

This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward

<p>Goldman Sachs  analyst Brooke Roach   maintains Warby Parker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) with a Buy and raises the price target from $18 to $20.</p>


WRBY

Goldman Sachs Maintains Buy on Warby Parker, Raises Price Target to $20

<p>Goldman Sachs  analyst Brian Lee   maintains Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) with a Neutral and lowers the price target from $27 to $20.</p>


VECO

Goldman Sachs Maintains Neutral on Veeco Instruments, Lowers Price Target to $20

<p>Goldman Sachs  analyst Brooke Roach   maintains Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) with a Buy and raises the price target from $84 to $93.</p>


Goldman Sachs Maintains Buy on Tapestry, Raises Price Target to $93

<p>Goldman Sachs  analyst Christine Cho   maintains Sweetgreen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) with a Neutral and lowers the price target from $27 to $23.</p>


Goldman Sachs Maintains Neutral on Sweetgreen, Lowers Price Target to $23

<p><strong>Needham </strong>analyst <strong>Quinn Bolton</strong> reiterated the Buy rating on <strong>D-Wave Quantum Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>), <a href="https://www.benzinga.com/quote/QBTS/analyst-ratings" target="_blank" rel="noreferrer noopener">raising the price forecast from $8.50 to $13</a>.</p>
<p>On Thursday, the company reported revenue of $15 million for the quarter ended March 31, a more than sixfold increase on a year-over-year basis. The revenue boost was largely driven by the first recognized sale of its Advantage quantum computing system to a major research institution and increased client adoption of its hybrid quantum solutions.</p>
<p>Bolton pointed out several key developments.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/25/05/45310899/quantum-computing-aids-energy-efficiency-for-blockchain-hashing-require-a-fraction-of-the-electricity-used-by-classical-resources-says-d-wave-ceo" rel="noreferrer noopener">Quantum Computing Aids Energy Efficiency For Blockchain Hashing: &#8216;Require A Fraction Of The Electricity Used By Classical Resources,&#8217; Says D-Wave CEO</a></strong></p>
<p>The sale of the Advantage system contributed to a strong revenue beat and a notable boost in next-generation gross margin, which came in at 93.6%, well above the Street estimate of 74.3%.</p>
<p>This indicates that system sales generate significantly higher margins compared to QCaaS revenue, the analyst writes.</p>
<p>The company also completed the installation of its Advantage2 system at Davidson in Alabama. Additionally, Bolton highlighted the company&#8217;s ongoing progress in quantum blockchain, including efforts to secure a partner for its go-to-market strategy.</p>
<p>Finally, the analyst noted that commercial interest has increased since the company&#8217;s quantum supremacy demonstration last quarter.</p>
<p>Bolton observed that D-Wave is making progress in the quantum blockchain space and is actively looking for a partner to help build a go-to-market strategy, which could lead to significant system sales opportunities if successful.</p>
<p>He mentioned that Ford Otosan is moving its deployment into production, with plans to expand across several factories.</p>
<p>According to Bolton, D-Wave&#8217;s growing technology portfolio and emphasis on practical, commercial use cases will likely drive stronger customer adoption and revenue growth.</p>
<p>However, he cautioned that since the company remains EBITDA-negative, investors should expect ongoing dilutive financing rounds until it reaches EBITDA break-even.</p>
<p><strong>Price Action</strong>: QBTS shares are trading higher by 2.16% to $10.64 at last check Friday.</p>
<p><strong>Read Next:</strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/general/market-summary/25/05/45251508/warren-buffett-falls-behind-nancy-pelosi-in-stock-market-returns-over-the-last-11-years-heres-what-data-shows" target="_blank" rel="noreferrer noopener">Warren Buffett Falls Behind Nancy Pelosi In Stock Market Returns Over The Last 11 Years: Here&#8217;s What Data Shows</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Markets

QBTS

D-Wave's Quantum Momentum Impresses Analyst, Sees Stronger Commercial Uptake Ahead

<p>Goldman Sachs  analyst Lizzie Dove   maintains Six Flags Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUN#NYSE">FUN</a>) with a Neutral and lowers the price target from $45 to $39.</p>


Goldman Sachs Maintains Neutral on Six Flags Entertainment, Lowers Price Target to $39

<p>Goldman Sachs  analyst  Richard Law   maintains Silence Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>) with a Sell and lowers the price target from $4 to $3.</p>


Goldman Sachs Maintains Sell on Silence Therapeutics, Lowers Price Target to $3

<p>Goldman Sachs  analyst Brooke Roach   maintains SharkNinja (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) with a Buy and raises the price target from $100 to $112.</p>


Goldman Sachs Maintains Buy on SharkNinja, Raises Price Target to $112

<p><strong>Solo Brands</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Solo Brands will report an <strong>earnings per share</strong> (EPS) of $-0.05. </p>
<p>Anticipation surrounds Solo Brands's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings Track Record</h3>
<p>The company's EPS missed by $0.10 in the last quarter, leading to a 9.54% drop in the share price on the following day.</p>
<p>Here's a look at Solo Brands's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.13</td>
<td>0.02</td>
<td>0.13</td>
<td>0</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.03</td>
<td>0.02</td>
<td>0.04</td>
<td>0.03</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-10.0%</td>
<td>-6.0%</td>
<td>8.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746814374_0.png" alt="eps graph" /></p>
<h3>Market Performance of Solo Brands's Stock</h3>
<p>Shares of Solo Brands were trading at $0.094 as of April 21. Over the last 52-week period, shares are down 95.3%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/DTC/earnings"><strong>To track all earnings releases for Solo Brands visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview: Solo Brands

<p>Ispire Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>) will release its quarterly earnings report on Monday, 2025-05-12. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Ispire Technology to report an <strong>earnings per share</strong> (EPS) of $-0.12.</p>
<p>Ispire Technology bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.07, leading to a 1.83% drop in the share price the following trading session.</p>
<p>Here's a look at Ispire Technology's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.07</td>
<td>-0.06</td>
<td>-0.09</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.14</td>
<td>-0.10</td>
<td>-0.03</td>
<td>-0.11</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>2.0%</td>
<td>2.0%</td>
<td>6.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746814362_0.png" alt="eps graph" /></p>
<h3>Performance of Ispire Technology Shares</h3>
<p>Shares of Ispire Technology were trading at $2.9 as of May 08. Over the last 52-week period, shares are down 50.75%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analysts' Perspectives on Ispire Technology</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Ispire Technology.</p>
<p>The consensus rating for Ispire Technology is Buy, derived from 1 analyst ratings. An average one-year price target of $9.0 implies a potential 210.34% upside.</p>
<h3>Peer Ratings Overview</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of  and Turning Point Brands, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Turning Point Brands, with an average 1-year price target of $85.0, suggesting a potential 2831.03% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for  and Turning Point Brands, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ispire Technology</td>
<td>Buy</td>
<td>0.34%</td>
<td>$7.72M</td>
<td>-29.11%</td>
</tr>
<tr>
<td>Turning Point Brands</td>
<td>Outperform</td>
<td>194.64%</td>
<td>$42.11M</td>
<td>1.30%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Ispire Technology ranks lower in revenue growth compared to its peer. It also has a lower gross profit margin. Additionally, its return on equity is negative, indicating lower profitability compared to its peer.</p>
<h3>Unveiling the Story Behind Ispire Technology</h3>
<p>Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.</p>
<h3>Ispire Technology: A Financial Overview</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Ispire Technology's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>0.34%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Ispire Technology's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>-19.12%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Ispire Technology's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-29.11%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Ispire Technology's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-6.13%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.12</strong>, Ispire Technology adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/ISPR/earnings"><strong>To track all earnings releases for Ispire Technology visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ISPR

Insights into Ispire Technology's Upcoming Earnings

<p>Goldman Sachs  analyst Mark Delaney   maintains Sensata Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) with a Buy and raises the price target from $27 to $30.</p>


Goldman Sachs Maintains Buy on Sensata Technologies, Raises Price Target to $30

<p>Goldman Sachs  analyst Richard Law   maintains Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) with a Neutral and lowers the price target from $15 to $13.</p>


RCKT

Goldman Sachs Maintains Neutral on Rocket Pharmaceuticals, Lowers Price Target to $13

<p>Village Farms Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) will release its quarterly earnings report on Monday, 2025-05-12. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Village Farms Intl to report an <strong>earnings per share</strong> (EPS) of $0.00.</p>
<p>Village Farms Intl bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Past Earnings Performance</h3>
<p>The company's EPS missed by $0.06 in the last quarter, leading to a 2.84% increase in the share price on the following day.</p>
<p>Here's a look at Village Farms Intl's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.03</td>
<td>-0.03</td>
<td>-0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.08</td>
<td>-0.01</td>
<td>-0.10</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>-7.000000000000001%</td>
<td>-5.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746814289_0.png" alt="eps graph" /></p>
<h3>Market Performance of Village Farms Intl's Stock</h3>
<p>Shares of Village Farms Intl were trading at $0.6481 as of May 08. Over the last 52-week period, shares are down 48.5%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/VFF/earnings"><strong>To track all earnings releases for Village Farms Intl visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Comments

Allurion Technologies

뉴스

에 대한 최신 뉴스 Allurion Technologies (NYSE:ALUR) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌